MADRIGAL PHARMACEUTICALS, INC. — Form 4
Filed November 6, 2026 · analyzed by the Insider Agent
4
▲ Likely positive
significance 78/100
What the filing says
Director BAKER BROS. ADVISORS LP (MDGL) bought 92K shares (~$35.0M) on the open market (4.3% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating
Open-market insider purchase — historically a bullish signal.
Tradability signal
NO TRADE
No trade: only ~$0k traded in the last 30 min — too illiquid to enter and exit. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it positive)
before filing · preread $399.93 ▼ 1.74% | at our read · unknown $407.00 | +10 min · unknown $405.13 ▼ 0.46% | +30 min · unknown $417.98 ▲ 2.70% | +1 hr · unknown $425.27 ▲ 4.49% | +4 hrs · unknown $428.51 ▲ 5.29% |
The stock had already moved +1.77% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.